Objective: To examine the effect of feeding type on microbial patterns among preterm infants and to identify feeding factors that promote the colonization of beneficial bacteria.
H uman gut microbiota refers to all microorganisms that reside in the digestive tracts of humans, including bacteria, viruses, fungi, and other microbes in which bacteria comprise most of the flora (Guarner & Malagelada, 2003) . The microbiome refers to the genomic elements of the whole microbiota (D'Argenio & Salvatore, 2015) . The gut microbial community benefits humans in many different ways, including the fermentation of indigestible dietary fiber into short-chain fatty acids (SCFAs), and provides essential chemical compounds such as hormones, essential fatty acids, and vitamins to maintain proper function of the human body. Gut microbiota also have important roles in the modification of host immune function and inflammatory responses to resist pathogenic organisms and in the regulation of the development of the gut defense systems (Boleij & Tjalsma, 2012; Quigley, 2013; Round & Mazmanian, 2009 ).
Our knowledge of bacteria communities continues to broaden along with culture-independent molecular techniques used to detect an expansive microbial world. Measures commonly used to evaluate gut microbiome include microbial alphadiversity (a-diversity), beta-diversity (b-diversity), abundance, and incidence of individual species (Lozupone & Knight, 2008; Morgan & Huttenhower, 2012) . The a-diversity is an estimate of the richness and evenness of the bacterial species in a community (Morgan & Huttenhower, 2012) . In most circumstances, a greater a-diversity is indicative of a healthier and more mature microbiome pattern, and it is often quantified with the Simpson Diversity Index and the Shannon Diversity Index in human gut microbiome studies. The b-diversity is a measure of the number or the presence/absence of species shared among microbial communities and evaluates the extent to which two or more communities differ among each other (Lozupone & Knight, 2008) . b-Diversity is also used to evaluate the changes of gut microbial community over time, for example, changes caused by environmental or disease status, and can be quantified with the Bray-Curtis Dissimilarity Index (Kapiki et al., 2007) .
Abundance and incidence are used to evaluate individual bacterial species. Abundance of a bacteria species refers to the number of individual species found in a community, whereas incidence is a measure of the frequency of each bacterial species found in communities. In general, greater abundance of beneficial microbiota, for example, Bifidobacterium and Lactobacillus, is more desirable, whereas pathogenic bacteria, including Escherichia coli (E. coli), Enterobacter, Citrobacter, Proteus, Klebsiella, and Candida, are less desirable in the promotion of gut health among preterm infants.
The alteration or imbalance of microbiota, also called dysbiosis or dysbacteriosis, can disrupt human wellness, particularly among vulnerable infants born prematurely (<37 weeks gestational age). Dysbacteriosis has been associated with increased risk of colic (Kianifar et al., 2014) and necrotizing enterocolitis in preterm infants (Thomas, 2016; Warner et al., 2016) and can lead to immune disorders (e.g., inflammatory bowel disease; Burcelin, 2016; Jiang et al., 2015; Marteau, 2009) , diabetes (Rozanova, Voevodin, Stenina, & Kushnareva, 2002) , obesity (Menni et al., 2017; Turnbaugh et al., 2009) , and cancer (Loo et al., 2017; Yamamoto & Matsumoto, 2016; Zhu, Gao, Wu, & Qin, 2013) later in life. Preterm infants, especially very-low-birth-weight infants, are susceptible to an imbalanced gut microbial community as the result of gut immaturity (Groer et al., 2014) . Other environmental factors that influence the development of a normal gut symbiosis in preterm infants may include perinatal/postnatal use of medication (i.e., intensive use of antibiotics), host genetic factors, mode of delivery, NICU environments, stressful early-life events, mother-infant contacts, feeding compositional differences, and practices during the perinatal period (Cong et al., 2016) .
Total fat in infant feedings comprises 40% of calories ingested. Evidence from human and animal investigations suggests that dietary fatty acid composition probably plays a role in gut microbiota development and composition (Balfegó et al., 2016; Ghosh, Molcan, DeCoffe, Dai, & Gibson, 2013; Noriega, Sanchez-Gonzalez, Salyakina, & Coffman, 2016; Pu, Khazanehei, Jones, & Khafipour, 2016) . Given this potential, it is important to consider that fatty acid composition and bioavailability differ among feedings provided to preterm infants on the basis of the type of feeding they are provided. Although the percentage of total calories from fat is similar between human milk and infant formula, the composition of specific fatty acids can vary widely on the basis of maternal factors (i.e., maternal diet, stage of lactation) or compositional differences between formula type provided (i.e., standard preterm, elemental; Robinson & Caplan, 2015) . These compositional differences affect percentage and form of saturated, monounsaturated, and long-chain polyunsaturated fatty acids provided to infants, with implications for microbiota development and associated health outcomes.
Prebiotics are the nondigestible food ingredients that stimulate the growth and/or activity of beneficial bacterial species (e.g., Bifidobacteria) and thereby potentially improve the health of the host (Gibson & Roberfroid, 1995) . Human alimentary enzymes are not able to digest most complex carbohydrates and plant polysaccharides. Instead, these polysaccharides are metabolized by microbes that generate SCFAs, including acetate, propionate, and butyrate (Holscher, 2017) . Oligosaccharides, well known as beneficial prebiotics for preterm infants, are contained in human milk (human milk oligosaccharides, HMOs), which has been shown to facilitate the growth of Bifidobacteria and Lactobacillus (Dai & Walker, 1999) . With regard to oligosaccharides, it is important to highlight that oligosaccharides are naturally abundant in human milk and are highly complex and structurally different from those added to infant formulas (Ninonuevo & Bode, 2008) . More than 200 HMOs have been found in human milk (Bier, German, & Lö nnerdal, 2008; German, Freeman, Lebrilla, & Mills, 2008; Ninonuevo et al., 2006) . The HMOs are not only complex in structure but vary from mother to mother, dependent on a mother's Lewis blood group and secretor status (Rudloff & Kunz, 2012) . Given the great amount of HMOs in the composition of human milk and the associated health benefits for infants, formula companies have attempted to find inexpensive alternatives, including galactooligosaccharides (GOS) and fructooligosaccharides (FOS), to mimic HMO. GOS and FOS have similar bifidogenic effects (ability to promote bifidobacterial growth) compared with HMOs (Boehm et al., 2002; Kapiki et al., 2007) . A structural difference with clinical significance relates to immunogenic properties of HMO. Although HMOs structurally resemble epithelial cell-surface glycans and block pathogen adhesion, structural differences in GOS and FOS may not yield the same protection from diarrhea and gastrointestinal infection (Newburg, Ruiz-Palacios, & Morrow, 2005) . Given structural differences, additional research related to the potential benefits of GOS and FOS in infant formulas is needed to further show related health outcomes and cost-effectiveness of large-scale use. Additionally, prebiotics are of specific research interest in relation to their promotion of microbes that produce SCFAs, which help with optimal functionality of the gut.
In contrast to prebiotics, probiotics refer to live microorganisms that are administered to the human body to attain optimal health. The commonly used probiotics in infants are Lactobacillus and Bifidobacterium species. The benefits related to probiotic use include reduction in pathogenic bacteria, increase in beneficial bacteria, improvement of food tolerance, and decreased incidence of nosocomial sepsis and necrotizing enterocolitis in preterm infants (Al-Hosni et al., 2012; Braga, da Silva, de Lira, & de Carvalho, 2011; Luedtke, Yang, & Wild, 2012) .
Feeding has been recognized as one of the most influential factors to contribute to the early development of the gut microbiome because milk is the first food to be introduced to the digestive tract in infancy (Cong et al., 2017; Gregory et al., 2016) . In addition, milk is often supplemented with prebiotics and probiotics to increase the colonization of beneficial bacteria and to promote the maturation of the gut community. However, the effects of different feeding regimens on gut microbiota patterns remain unclear. The purpose of this systematic review was twofold: to describe the patterns of microbial communities in infants with different feeding types and to identify the optimal feeding types to promote the colonization of beneficial bacteria among preterm infants.
Methods

Eligibility Criteria of the Literature
To conduct this systematic review, we followed the guidelines in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for reporting systematic reviews (Liberati et al., 2009) . Original research studies on the effect of enteral feeding types on gut microbiological composition and diversity were included. Articles were written in English and published after January 2000. No restrictions on study design were imposed.
We targeted research conducted with preterm infants who were born at or less than 37 weeks gestational age, were recruited after birth to 30 days of postnatal age, and were followed up for 2 weeks or longer. Studies of preterm infants with congenital anomalies, severe periventricular/ intraventricular hemorrhage, who underwent major surgery, or had histories of positive drug exposure were excluded. The primary outcome measures were gut microbiome patterns, including the a-diversity, b-diversity, and abundance of specific bacteria of the gut microbiome. Predicting variables included enteral feeding types, mothers' own milk (MOM), donor human milk (DHM), infant formula, and dose and frequency of use of prebiotics and/or probiotics. Studies that involved in vitro fecal batch cultures or animal gut microbiomes were excluded from the review.
Information Sources and Search Strategies
To identify eligible studies, research databases were systemically searched, including PubMed, Cochrane Database of Systematic Reviews, Scopus, and the Cummulative Index of Nursing and Allied Health Literature. Keywords used included gut microbiome, gut microbiota, enteral
The purpose of this systematic review was to examine the association between feeding types and the development of the gut microbiome in preterm infants. Xu, W. et al. I N F O C U S microbiome, enteral microbiota, premature infant, preterm infant, extremely low birth weight infant, ELBW infant, very low birth weight infant, feeding, breast milk, breastfeeding, and formula. The last search was run on January 31, 2017. In addition, we manually searched the reference pages of the reviewed studies.
Study Selection
The studies were screened by two reviewers independently in an unblinded, standardized manner on the basis of the eligibility criteria. Disagreements between reviewers were resolved through mutual agreement. If agreement was not achieved, a third reviewer was involved for a final decision.
Data Extraction
All selected articles were independently reviewed by two researchers who used a predefined data extraction form that was modified on the basis of the Cochrane Consumers and Communication Reviews Group's data extraction template and adapted for use in the assessment of nonrandomized studies. Information on the studies, including author, country, year, study design, study participants, type of feeding, type and frequency of biospecimen (e.g., feces, gastric aspirate) collection, microbiological analysis method, and major results, was collected by each researcher independently, and consensus between two reviewers was achieved through discussion.
Risk of Bias
The internal validity of each individual study was evaluated using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) guidelines (Balshem et al., 2011) . In accordance with the GRADE rating approach, randomized controlled trials (RCTs) were rated as high-quality evidence, and reviewers needed to consider features such as randomization, allocation concealment, blinding, and completeness of the outcome data. In contrast, observational studies were rated as low-quality evidence and evaluated by appropriate measurement of exposure and outcome, effective control of confounding, and the extent of loss to follow up.
Data Analysis
The evidence on gut microbiota outcomes were grouped according to feeding regimens, including milk category (MOM, DHM, and infant formula) and use of prebiotics and/or probiotics. Studies on the same bacterial species were grouped together for analysis. Studies in which microbial a-diversity (the richness and/or evenness of a microbiome community) and b-diversity (the compositional dissimilarity among the microbial community) were measured by use of the same methods were also grouped and analyzed together in the same category.
Results
Selection of the Literature
A total of 136 articles were identified through the search. The titles and abstracts were reviewed to exclude articles that were not related to the research questions. One hundred seven articles were excluded after the first screening, including 92 articles that were not relevant and 11 duplicates. The remaining 33 research articles were evaluated by review of the full text, and 12 were further excluded because the authors used in vitro study designs, and the articles thus did not meet inclusion criteria. Meanwhile, three pairs of articles were identified as duplicates of the same study in different journals; we selected the one of each pair that reported the full data set. In total, 18 articles were identified as eligible for the final systematic review. No doctoral dissertations or unpublished articles were included. Details related to the search strategy are shown in the PRISMA flow diagram in Figure 1 .
Methodologies Used in the Included Studies
Of the studies included, six were conducted in the United States (Cong et al., 2017; Gregory et al., 2016; La Rosa et al., 2014; Patel, Konduru, Patra, Chandel, & Panigrahi, 2015; Underwood et al., 2013; Underwood et al., 2014) , two in France (Campeotto et al., 2011; Rougé et al., 2009) , two in Germany (Boehm et al., 2002; Mohan et al., 2006) , two in Italy (Manzoni et al., 2006; Romeo et al., 2011) , one in Iran (Armanian et al., 2016) , one in the Netherlands (Westerbeek et al., 2013) , one in Greece (Kapiki et al., 2007) , one in Spain (Moles et al., 2015) , one in Poland (ChrzanowskaLiszewska, Seliga-Siwecka, & Kornacka, 2012) , and one in Japan (Li et al., 2004) . Two studies were observational (Cong et al., 2017; La Rosa et al., 2014) , two were prospective cohort (Gregory et al., 2016; Patel et al., 2015) , and one was quasi-experimental without a control group (Moles et al., 2015) ; the remaining articles were randomized controlled trials (see Supplemental  Tables S1-S3 ). In terms of microbiological analyses, in 3 of the studies the authors used 16S
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I N F O C U S rRNA next-generation sequencing, in 2 they used terminal restriction fragment length polymorphism, in 2 they used temporal temperature gel electrophoresis, in 2 they used fluorescent in situ hybridization, in 1 they used pulsed-field gel electrophoresis, and in 10 they used a culture method. Among these, authors in four studies combined the culture method with other analysis technology (see Supplemental Tables S1-S3 ).
Relation of Feeding Types and Gut Microbiome
Preterm infants who were fed with MOM had greater initial a-diversity of their gut microbial communities (Cong et al., 2017; Gregory et al., 2016) . Microbial a-diversity index in infants fed with DHM and formula remained lower during the first 30 days of life (Cong et al., 2017) , then increased to a relatively greater level at 60 days after birth or 40 weeks adjusted gestational age compared with infants fed with MOM (Gregory et al., 2016) . Furthermore, a-diversity in infants fed with DHM and formula had greater variance across participants compared with the infants fed with MOM, which indicated their susceptibility to the influence of other factors, especially birth gestational age and birth weight (Gregory et al., 2016) .
Gut microbial b-diversity measured with the use of the Bray-Curtis Dissimilarity Index indicated that infants fed with MOM clustered together (high similarity) and were separate from infants fed with DHM and formula (Cong et al., 2017; Gregory et al., 2016) . Cong et al. (2017) also reported that feeding type explained 11% of the variance in the community composition (p < .001). In addition, the structure of gut microbial community in infants fed with MOM was less susceptible to the influence of birth weight than in infants fed with formula, who were reported to have a more scattered plot distribution or dissimilarity by birth weight (p < .01; Gregory et al., 2016) .
Two groups of researchers reported that infants fed with MOM had greater levels of Clostridiales than did infants fed in other ways (Cong et al., 2017; Gregory et al., 2016) . La Rosa et al. (2014) reported that the use of MOM for
Records iden fied through database search using keywords (see the Methods sec on; n = 131) Addi onal records iden fied through other sources (n = 5 )
Records screened a er duplicates (n = 11) removed (n = 125)
Records excluded (i.e., animal studies, full-term infants, without follow up; without gut microbial outcomes; n = 92) Full-text ar cles assessed for eligibility (n = 33)
Full-text ar cles excluded, (didn't meet inclusion criteria, i.e., in vitro studies; duplicated studies; n = 15) Studies included in quan ta ve synthesis (n = 18) Mother's own milk is the best type of nutrition to promote the maturation of infant gut microbiota to resemble a more adult-like microbial structure. Xu, W. et al. feedings was associated with increased colonization of Gammaproteobacteria (p < .04). Within this class, the association between the colonization of Enterbacteriales and feedings with MOM remains controversial across investigations (Cong et al., 2017; Gregory et al., 2016) . Gregory et al. (2016) reported that infants fed with formula had delayed development of Enterbacteriales compared with infants fed with MOM, whereas Cong (2017) reported greater Enterbacteriales colonization in infants fed with DHM and formula compared with infants fed with MOM throughout the first 30 days of life. Similarly, a lack of congruence existed across investigations in the association between infants fed with MOM and Lactobacillales and Bacillales colonization (Cong et al., 2017; Gregory et al., 2016) . No difference was reported for the effect of infants fed with MOM and formula and the colonization of Lactobacillus (Patel et al., 2015) . Of interest, Cong et al. (2017) reported that infants who were fed with a combination of MOM and formula had greater colonization of Bifidobacteriales. Similarly, within the order of Bifidobacteriales, infants fed with MOM had greater levels of Bifidobacteria than did infants fed with DHM and formula (Patel et al., 2015) . In summary, the use of MOM for feedings promoted rich gut microbial communities and supported the development of Clostridiales and Bifidobacteria colonizations, compared with the use of feedings from other sources (see Supplemental Table S1 ).
Relation of Prebiotic Use and Gut Microbiome
Human milk oligosaccharides are structurally diverse glycans found primarily in human milk. Numerous variations in structure and concentration of HMOs have been found among individual infants and over the course of lactation (Chaturvedi et al., 2001) . Several researchers found that HMOs were associated with protective effects that included the inhibition of adhesion and invasion of pathogenic microorganisms to the intestinal epithelial wall (Gonia et al., 2015 ; Ruiz-Palacios, Cervantes, Ramos, Chavez-Munguia, & Newburg, 2003) , regulation of bacteria-host interactions, and modulation of microbial composition of human gut (Bode, 2009 ).
GOS and FOS are commercial prebiotics with bifidogenic effects similar to those of HMO. Underwood et al. (2014) compared the bifidogenic effects between GOS and HMO in preterm infants fed with formula and reported no differences in a-diversity or individual species including Proteobacteria, Bacilli, Bifidobacteria, or Clostridia over time (Underwood et al., 2014) . Kapiki (2007) reported that preterm infants given formula feeding regimens that included a supplement of FOS (0.4 g/100 ml) had significantly greater numbers of Bifidobacteria at Day 7 after the infants reached full formula feeding compared with the placebo group. In addition, the FOS-supplemented feeding group had lower concentrations of E. coli, Bacteroides, and Enterococci than did the non-FOS cohorts (Kapiki et al., 2007) .
Three groups of researchers investigated the effects of the GOS/FOS combination on the gut microbial composition and reported contradictory results (Armanian et al., 2016; Boehm et al., 2002; Westerbeek et al., 2013) . Armanian et al. (2016) observed that preterm infants fed with breast milk and supplemented with GOS/FOS (9:1) had significantly greater colony counts of Lactobacillus and lower counts of Coliforms over the three study time points than did infants in the control group. The difference disappeared at the last study point for Lactobacillus when the feeding volume reached 110 to 150 ml À1 , kg À1 , day À1 . In contrast, Boehm et al. (2002) reported no difference in the colony counts of Lactobacilli between the GOS/ FOS (9:1) group and placebo group at any of the four study points. In addition, colony counts of potentially pathogenic microorganisms, including Bacteroides, Clostridium species, E. coli, Enterobacter, Citrobacter, Proteus, Klebsiella, and Candida, were similar in both groups (Boehm et al., 2002) . Westerbeek et al. (2013) reported results similar to those of Boehm et al. and found that infants supplemented with a prebiotic mixture with 80% GOS/ FOS (9:1) and 20% acidic oligosaccharides had greater Bifidobacteria counts compared with those in the control group (Boehm et al., 2002; Westerbeek et al., 2013) . The overall results indicated that prebiotics were bifidogenically efficient in stimulating the growth of Bifidobacteria (see Supplemental Table S2 ).
Supplementation with prebiotics and/or probiotics may promote development of beneficial microorganisms, particularly microbes that generate short-chain fatty acids and Bifidobacterium colonization in preterm infants.
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Relation of Probiotic Use and Gut Microbiome
Researchers in 9 of the 18 included articles assessed the effects of probiotics on gut bacterial colonization; increased abundance or incidence of Bifidobacteria and/or Lactobacillus after treatment with a probiotic was found in five studies (Chrzanowska-Liszewska et al., 2012; Li et al., 2004; Mohan et al., 2006; Rougé et al., 2009; Underwood et al., 2013) . Li et al. (2004) found that introduction of Bifidobacteria breve (B. breve) supplementation within 24 hours of life was associated with early colonization of Bifidobacteria (3.4 AE 2.2 day) and decreased abundance of Enterobacteriaceae 2 weeks after birth (p < .05). No statistical difference was reported in the rates or abundance of Streptococcus and Staphylococcus in association with B. breve supplementation (Janvier, Malo, & Barrington, 2014) . Similarly, Mohan et al. (2006) conducted an RCT and reported that infants supplemented with Bifidobacterium lactis (B. lactis) group had a greater abundance of Bifidobacteria and lower abundance of Clostridia and Enterobacteriaceae of gut microbiome compared with the control group. The investigators also reported no difference between the probiotics and control groups in the levels of Staphylococcus spp., Streptococcus spp., Bacteoides spp., and Candidia spp. Rougé et al. (2009) evaluated the effect of combined supplementation of Bifidobacterium longum and Lactobacillus rhamnosus on gut microbiota compositions. The incidence of gastrointestinal colonization of Bifidobacteria and Lactobacilli was significantly greater in the probiotic group than in the control group. Chrzanowska-Liszewska et al. (2012) conducted a double-blind RCT in preterm infants born at less than 32 weeks gestational age and found that infants fed with formula and supplemented with Lactobacillus rhamnosus during the first 42 days had greater incidence of Lactobacillus on Day 7 and Day 21 postnatal age but not on Day 42 than infants in the control group. In contrast to the findings of previous investigators, ChrzanowskaLiszewska and colleagues reported that infants in the probiotic group had greater incidence of Enterobacteriaceae, Enterococcus, and Staphylococcus than did infants in the control group.
In contrast, some investigators found no relationship between the use of probiotics and gut microbial development. Campeotto et al. (2011) reported that the combination of heatkilled B. breve, Streptococcus thermophiles strain, and nondigestible oligosaccharides added to formula and fed to preterm infants did not alter bacterial colonization, including Bifidobacteria, Lactobacilli, E. coli, Klebsiella, and Enterobactor cloacae. In a one-group pretestposttest study with five preterm infants born at less than 29 weeks gestational age, Moles (2015) reported that the supplementation of B. breve/ L. salivarius had no modifying effect on the colonization of Bifidobacteria, Lactobacillus, and a-diversity of the microbial community, although
Enterococcus decreased over time after introduction of the probiotics.
To investigate the effects of two strains of probiotics on the gut microbial community in preterm infants, Underwood et al. (2013) conducted two trials and found that a-diversity increased over time and with the escalation of dose among infants fed with formula and supplemented with Bifidobacterium infantis (B. infantis) compared with infants fed with formula and supplemented with B. lactis. The relative abundance of Bifidobacteria was greater in the B. infantis group compared with the cohort who received B. lactis. In addition, early administration of B. infantis was associated with increased abundance of Bifidobacteria and decreased Proteobacteria in the intestinal tract (Underwood et al., 2013) .
Three groups of investigators examined the effect of probiotics on fungal colonization, and two reported reduction of fungi after a treatment with probiotics. Manzoni et al. (2006) implemented a 6-week, double-blind RCT in low-birth-weight, preterm infants and found that Lactobacillus rhamnosus supplementation with breast milk (MOM or DHM) was associated with a significant reduction in the number of fungal isolates per infant and incidence of fungal colonization, particularly in infants who weighed more than 1,000 g at birth. Romeo et al. (2011) compared the effects of Lactobacillus reuteri and Lactobacillus rhamnosus and also found that both probiotic strains lowered the incidence of gut fungal colonization. In contrast, Mohan et al. (2006) found that consumption of the B. lactis supplement did not reduce the abundance of Candida in the gut of preterm infants fed with formula. Overall, results related to probiotic use and bacterial species in the gut communities of preterm infants were contradictory. Nevertheless, the majority of the investigators supported the positive effect of probiotics on the growth of Bifidobacterium and the reduction of fungal colonization (see Supplemental Table S3 ). Xu, W. et al. 
I N F O C U S
Discussion
Our primary findings include the following: (a) Feedings with MOM influence the compositional structure of preterm infants' gut microbial community and increase diversity of gut microbiota compared with DHM and formula; (b) breast milk contains complex oligosaccharides, lactoferrin, and beneficial bacteria that stimulate the growth of specific bacterial groups such as Clostridiales and Bifidobacteria; (c) supplementation with commercial prebiotics, particularly GOS and FOS, promotes the development of Bifidobacteria colonization; and (d) supplementation with probiotics may increase the colonization of beneficial bacteria, particularly Bifidobacterium and Lactobacilli, and inhibit fungal colonization.
Feedings with MOM are effective to improve infant gut health by increasing the diversity of the gut microbial community and promoting the maturation of gut microbiota and early transition to a more adult-like microbial composition. Although the extant evidence regarding feeding and microbiota development in preterm infants is focused on type of milk provided, recent evidence supports the need for more careful consideration of the specific composition, which varies across milk types. Given a significant contribution of dietary fat, 40% of total calories, evidence from human and animal investigations in other populations support an interaction between specific dietary fatty acid components and gut microbiota composition (Balfegó et al., 2016; Ghosh et al., 2013; Noriega et al., 2016; Pu et al., 2016) . Maternal factors that include diet, stage of lactation, and term or preterm birth can affect the fatty acid composition of human milk. Additionally, the fat blend and composition of specific fatty acids in infant formulas vary between manufacturers and between products produced by the same manufacturer, dependent on the formula used and clinical necessity (Robinson & Caplan, 2015) .
Although we identified a gap in the literature related to fatty acid composition and microbiota composition in preterm infants, in several recent investigations researchers showed that gut microbial composition is significantly affected by dietary long-chain polyunsaturated fatty acid (LCPUFA; Balfegó et al., 2016; Ghosh et al., 2013; Noriega et al., 2016; Pu et al., 2016) . The omega-3 LCPUFA docosahexaenoic acid (DHA), an antiinflammatory fatty acid, beneficially altered microbiota composition in human (Balfegó et al., 2016; Pu et al., 2016) and mouse (Yu et al., 2014 ) models. These microbial benefits related to omega-3 LCPUFA have been associated with increased composition of butyrate-producing bacteria (Noriega et al., 2016) . The SCFA butyrate has been associated with optimal functional microbiota function and associated outcomes (Holscher, 2017) . In contrast, in an animal model, a high level of proinflammatory omega-6 LCPUFA was associated with dysbiosis of gut microbiota (Ghosh et al., 2013) . Collectively, these researchers found evidence to support the role of high omega-3 LCPUFA levels in modulating the gut environment and influencing better microbiota composition. Further work is necessary to evaluate the contribution of specific dietary components, including associations among omega-3 LCPUFA, microbial diversity, and type (Robinson & Caplan, 2015) . DHM, although a preferable alternative for feedings for preterm infants, is less effective to promote the growth of beneficial bacteria and the diversity of the entire gut community than is MOM (Cong et al., 2017; Gregory et al., 2016) . This may be explained by the pasteurization process and destruction of the immunologic, nutritional, and microbial components in DHM that impair the interaction of the microbiome and oligosaccharides (Landers & Hartmann, 2013; Neu, 2015; Reeves, Johnson, Vasquez, Maheshwari, & Blanco, 2013) . Of interest, evidence suggests that formula may be effective to increase beneficial bacteria, particularly Lactobacillales (Gregory et al., 2016) and Bifidobacteriales (Cong et al., 2017) . Because the ingredients and the manufacturers of the formulas used in each study were not reported, the evidence is unclear with regard to how preterm infant formula could promote the growth of certain bacteria. One possible explanation is that some formula has been fortified with probiotics and/or prebiotics that support the proliferation of Bifidobacteria and Lactobacillus.
Prebiotic are nondigestible food ingredients that promote the growth and/or activity of beneficial microorganisms. Prebiotics pass through the upper gastrointestinal system unabsorbed and selectively stimulate the intestinal bacteria, especially Bifidobacteria and lactic acid bacteria, which are associated with health (Gibson, Probert, Loo, Rastall, & Roberfroid, 2004) . The findings of this review showed that commercial oligosaccharides, specifically GOS and FOS, are effective to promote the colonization of Bifidobacteria in the digestive tracts of preterm infants,
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I N F O C U S although the overall effect of these oligosaccharides on intestinal health remains to be studied. This result is consistent with the conclusion from the systematic review by Srinivasjois, Roa, and Patoles in 2013. There may be undesirable side effects related to commercially available prebiotics. In an animal study, researchers found evidence to indicate that supplementation of GOS/inulin increases bacterial translocation in newborn rats (Barrat et al., 2008) . However, no researchers have reported bacterial translocation among preterm infants. Notably, in the studies included in the review, researchers reported that supplementation of prebiotics to preterm infants was safe and well-tolerated without adverse effects such as diarrhea, food intolerance, fluid imbalance, abdominal distention, vomiting, or weight loss (Armanian et al., 2016; Boehm et al., 2002; Kapiki et al., 2007; Underwood et al., 2014; Westerbeek et al., 2013) . Therefore, more investigations are needed to evaluate the efficacy and safety of the use of prebiotics in preterm infants.
Probiotics are live microorganisms that provide a health benefit to the host when administered in adequate doses (Hill et al., 2014) . It is well known that probiotics are associated with the inhibition of pathogenic bacteria, normalization of perturbed microbiota, and restoration of a healthy microbiota community (Reid et al., 2011) . Previous researchers found that administration of probiotics in preterm infants was associated with increased feeding tolerance (Aceti et al., 2016; Whelan, 2007; Whelan, Gibson, Judd, & Taylor, 2001) , reduced incidence of necrotizing enterocolitis and sepsis (AlFaleh & Anabrees, 2014; Deshpande, Rao, & Patole, 2007; Deshpande, Rao, Patole, & Bulsara, 2010; Ferná ndezCarrocera et al., 2013; Guthmann et al., 2010; Janvier et al., 2014; Mihatsch et al., 2012; Wang, Dong, & Zhu, 2012) , and better neurologic and immunologic outcomes (Romeo et al., 2011) . Researchers also showed the safety of enteric administration of probiotics, especially certain strains of Bifidobacteria and Lactobacillus in preterm infants. Nevertheless, the results of this review highlight controversial effects of probiotics on the microbiome patterns. Several articles in this review included the nonsignificant bifidogenic effects of the use of probiotics with preterm infants. The reasons are multifactorial and may be related to the efficacy of specific manufacturing processes, doses and frequency of use related to each probiotic strain, analytic issues, or the combination of these factors.
Despite discrepancies, in most of the studies, researchers showed positive effects of probiotics on the development of the gut microbiota of preterm infants.
Strengths and Limitations of the Review Method
We used PRISMA as the reporting guideline to ensure quality. Furthermore, we used GRADE to examine the quality of the evidence from original studies and to minimize the risk of bias. Limitations of the review process also must be considered. In several of the studies included, the designs and interventions were not thoroughly described. Moreover, the doses/frequencies of the interventions and the outcome measurements of gut microbiome communities differed among studies, which impeded the synthesis of the findings. Last, we only included articles published in English, which may limit the credibility and generalizability of the findings.
Strengths and Limitations of the Evidence From the Review
It is still a challenge to investigate gut microbiome and infant feeding because there are no standard measures with which to evaluate and analyze microbial taxa. Rapid advances in microbial community sequencing have now made it possible to conduct large-scale studies to compare the effects of feedings with MOM, DHM, and formula on gut microbial development in preterm infants; however, to date, few such studies have been reported. Findings from the studies synthesized in this review indicated an inconsistent relationship between feeding types and gut microbiome patterns in preterm infants. Agreement on observed colonization patterns of some specific bacteria across different studies was challenging, which may be because of differences in microbiome isolation, sequencing and analysis techniques, or the limited sizes of studies published to date. In a recent review, researchers highlighted that older, culturedependent methodologies, although useful in the isolation of specific bacterial strains, cannot be used to adequately identify the pattern of a microbial community because of the absence of account for the uncultivable microorganisms (Arnold, Roach, & Azcarate-Peril, 2016) . Authors of several studies in this review used 16S rRNA isolation combined with denaturing gradient gel electrophoresis, pulsed-field gel electrophoresis, terminal restriction fragment length polymorphism, or temporal temperature gel electrophoresis methods to detect the differences Xu, W. et al. I N F O C U S between microbial communities. However, with these techniques, the researchers were not able to generate taxonomic structures of microbial communities. Only three groups of researchers used next-generation DNA sequencing to analyze the 16S rRNA gene. Although use of this technique provides richer information about complex microbial communities, it has only recently become cost effective. Targeted gene sequencing has several potential biases as a result of its reliance on polymerase chain reaction to generate material for sequencing, including primer efficiency, polymerase chain reaction amplification conditions, sequences platform, bioinformatics pipeline, and protocols for DNA extraction (Arnold et al., 2016; Huse, Ye, Zhou, & Fodor, 2012) .
In addition to the technical issues associated with data analysis, other factors that led to variation in results across investigations included differences in gestational ages of the study populations; modes of delivery; different enteral feeding practices; manufacture of the preterm infant formulas, prebiotics, and probiotics; and medication use, especially antibiotic use protocols. Moreover, a NICU's environmental influences, such as the environmental microbial composition and differences in hygiene protocols for health care providers and visitors, may also bias the microbiome outcomes across the studies.
Conclusion
Mothers' own milk is the most beneficial form of nutrition for preterm infants and their gut microbial communities. As health care providers, we must discuss the benefits of breast milk and encourage breastfeeding among mothers who give birth to preterm infants. Furthermore, nutritional education for breastfeeding mothers to support optimal breast milk composition may have implications for early microbiota establishment. When MOM is not available, the use of DHM or formula supplemented with prebiotics and/or probiotics is a plausible option to optimize the microbial community structure, but the definitive data on dose and efficacy of these products has not been determined.
Although multiple investigators have evaluated the effects of feeding type on the gut microbiomes of preterm infants, most focused on feeding type and did not consider the potential influence of individual nutritional components that include LCPUFAs. Investigation of the functionality of the gut microbiome in preterm infants and production of SCFAs could further our understanding of the roles of gut microbes and their associated functions in this specific population.
